OTC · Biotechnology

Universal Ibogaine Inc. (IBOGF) Stock

$0.02 +6.82% OTC: IBOGF Healthcare

Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction.

Valuation

MetricValue
Price$0.02
Market Cap$7.35M
P/E Ratio-0.09
P/B Ratio0.24
P/S Ratio1.46
EPS (TTM)$-0.06
52-Week High$0.35
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-304.82%
ROA-166.14%
ROCE8.75%
Gross Margin100.00%
Operating Margin46.43%
Net Margin-980.22%
Debt/Equity0.44
Current Ratio1.60

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$1.0M
Operating Profit$0$0$0$-4.0M$0
Net Profit$0$0$0$-4.0M$-10.0M
EPS$-0.04$-0.01$-0.01$-0.03$-0.06
Op Margin————46.4%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$0$0$0$4.0M$6.0M
Total Liabilities$0$0$0$1.0M$2.0M
Cash$0$0$0$0$1.0M
Borrowings$0$0$0$0$2.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$0$-3.0M$-4.0M
Investing Cash Flow$0$0$0$0$-2.0M
Financing Cash Flow$0$0$0$1.0M$1.0M
Net Cash Flow$0$0$0$0$1.0M
Free Cash Flow$0$0$0$-3.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.56
FCF Yield-283.12%
Quick Ratio1.60
Interest Coverage7.34
Return 1Y11.39%
Return 3Y150.00%
Return 5Y—

Ownership

Insiders Held13.44%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Universal Ibogaine Inc.

Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Canada.

Universal Ibogaine Inc. is headquartered in CA.

Universal Ibogaine Inc. (IBOGF) stock trades at $0.02 with a market capitalization of $7.35M. The stock is valued at a price-to-earnings (P/E) ratio of -0.09, price-to-book of 0.24, price-to-sales of 1.46. Over the past 52 weeks the stock has ranged between $0.00 and $0.35, and currently trades 94.3% below its 52-week high.

On profitability, Universal Ibogaine Inc. generates a return on equity (ROE) of -304.82%, return on capital employed of 8.75%, an operating margin of 46.43%, a net profit margin of -980.22%.

Official website: universalibogaine.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides